Uncategorized
High drug prices result of government protection in US
The high cost of prescription drugs in the United States is the result of drug manufacturers being granted government-protected monopolies, according to data published in JAMA Internal Medicine.“The increasing cost of prescription drugs in the United States has become a source of growing concern for patients, prescribers, payers and policy makers,” Aaron S. Kesselheim, MD, JD, MPH, of the department of medicine at Brigham and Women’s Hospital and Harvard Medical School, and colleagues wrote. “In addition to their contribution to health care spending, increasing drug costs have important clinical implications. (Read more...)